PharmaEssentia Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	13,815	9,735	5,106	2,882	656.51	557.26
Revenue Growth (YoY)	66.04%	90.67%	77.15%	339.00%	17.81%	82.29%
Cost of Revenue	1,496	1,177	610.54	812.29	378.86	373.32
Gross Profit	12,319	8,558	4,495	2,070	277.65	183.93
Selling, General & Admin	5,183	4,234	4,184	2,672	1,827	977.41
Research & Development	3,228	2,588	2,224	1,426	1,273	922.38
Operating Expenses	8,411	6,822	6,408	4,098	3,100	1,900
Operating Income	3,908	1,736	-1,913	-2,028	-2,822	-1,716
Interest Expense	-25.07	-22.19	-46.69	-18.53	-9.97	-8.26
Interest & Investment Income	721.81	924.06	585.13	40.44	4.63	7.49
Currency Exchange Gain (Loss)	-754.86	376.38	375.7	122.36	-1.85	9.82
Other Non Operating Income (Expenses)	-24.56	-18.74	12.33	42.15	4.09	-264.94
EBT Excluding Unusual Items	3,823	2,996	-986.93	-1,842	-2,826	-1,972
Gain (Loss) on Sale of Assets	-1.12	-0.93	-	-0.1	-0.07	0.02
Other Unusual Items	-	-	-	-	14.59	23.71
Pretax Income	3,822	2,995	-986.93	-1,842	-2,811	-1,948
Income Tax Expense	-982.24	29.15	-363.1	-467.06	-	0.13
Net Income	4,804	2,966	-623.84	-1,375	-2,811	-1,948
Net Income to Common	4,804	2,966	-623.84	-1,375	-2,811	-1,948
Shares Outstanding (Basic)	369	367	358	315	289	269
Shares Outstanding (Diluted)	371	371	358	315	289	269
Shares Change (YoY)	0.44%	3.59%	13.47%	9.24%	7.39%	10.55%
EPS (Basic)	13.03	8.07	-1.74	-4.36	-9.74	-7.25
EPS (Diluted)	12.95	8.00	-1.74	-4.36	-9.74	-7.25
Free Cash Flow	3,025	1,685	-1,996	-1,818	-2,532	-1,536
Free Cash Flow Per Share	8.15	4.54	-5.58	-5.76	-8.77	-5.71
Dividend Per Share	0.990	0.990	-	-	-	-
Gross Margin	89.17%	87.91%	88.04%	71.82%	42.29%	33.01%
Operating Margin	28.29%	17.83%	-37.48%	-70.37%	-429.91%	-307.91%
Profit Margin	34.78%	30.46%	-12.22%	-47.70%	-428.17%	-349.60%
Free Cash Flow Margin	21.90%	17.31%	-39.09%	-63.06%	-385.74%	-275.72%
EBITDA	4,031	1,847	-1,824	-1,912	-2,703	-1,621
EBITDA Margin	29.18%	18.97%	-35.73%	-66.34%	-	-290.92%
D&A For EBITDA	123.15	110.52	89.24	116.28	119.59	94.7
EBIT	3,908	1,736	-1,913	-2,028	-2,822	-1,716
EBIT Margin	28.29%	17.83%	-37.48%	-70.37%	-	-
Effective Tax Rate	-	0.97%	-	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.